These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1893425)

  • 1. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of the blood group antigens A and B in carcinoma of the urinary bladder].
    Tichý M; Jansa P; Student V; Tichá V; Vanák J
    Bratisl Lek Listy; 1992 Aug; 93(8):415-20. PubMed ID: 1464022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
    Murshidi MS
    Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course.
    Limas C; Lange P; Fraley EE; Vessella RL
    Cancer; 1979 Dec; 44(6):2099-107. PubMed ID: 509389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of blood groups and transitional cell carcinoma of the bladder.
    Kirkali Z; Eryigit M
    Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
    Klatte T; Xylinas E; Rieken M; Kluth LA; Rouprêt M; Pycha A; Fajkovic H; Seitz C; Karakiewicz PI; Lotan Y; Babjuk M; de Martino M; Scherr DS; Shariat SF
    J Urol; 2014 May; 191(5):1238-43. PubMed ID: 24333243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of A, B and H(O) antigens in normal and neoplastic epithelium of the urinary bladder by the specific red cell adherence test (SRCA).
    Kato T
    Tohoku J Exp Med; 1977 Mar; 121(3):239-46. PubMed ID: 857340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Words of wisdom. Re: Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
    Ohno Y
    Eur Urol; 2014 Aug; 66(2):391. PubMed ID: 25305789
    [No Abstract]   [Full Text] [Related]  

  • 16. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABH isoantigens in stage O papillary transitional cell carcinoma of the bladder: correlation with biological behavior.
    D'Elia FL; Cooper HS; Mulholland SG
    J Urol; 1982 Apr; 127(4):665-7. PubMed ID: 7069827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ
    Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
    [No Abstract]   [Full Text] [Related]  

  • 19. A,B blood group antigens in tissues of AB heterozygotes. Emphasis on normal and neoplastic urothelium.
    Limas C
    Am J Pathol; 1990 Nov; 137(5):1157-62. PubMed ID: 2240163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood group isoantigen deletion and chromosomal abnormalities in bladder cancer.
    Pauwels RP; Schapers RF; Smeets AW; Jansen LE; Debruyne FM; Geraedts JP
    J Urol; 1988 Nov; 140(5):959-63. PubMed ID: 3050155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.